Your browser doesn't support javascript.
loading
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition).
Zhou, Jian; Sun, Huichuan; Wang, Zheng; Cong, Wenming; Zeng, Mengsu; Zhou, Weiping; Bie, Ping; Liu, Lianxin; Wen, Tianfu; Kuang, Ming; Han, Guohong; Yan, Zhiping; Wang, Maoqiang; Liu, Ruibao; Lu, Ligong; Ren, Zhenggang; Zeng, Zhaochong; Liang, Ping; Liang, Changhong; Chen, Min; Yan, Fuhua; Wang, Wenping; Hou, Jinlin; Ji, Yuan; Yun, Jingping; Bai, Xueli; Cai, Dingfang; Chen, Weixia; Chen, Yongjun; Cheng, Wenwu; Cheng, Shuqun; Dai, Chaoliu; Guo, Wengzhi; Guo, Yabing; Hua, Baojin; Huang, Xiaowu; Jia, Weidong; Li, Qiu; Li, Tao; Li, Xun; Li, Yaming; Li, Yexiong; Liang, Jun; Ling, Changquan; Liu, Tianshu; Liu, Xiufeng; Lu, Shichun; Lv, Guoyue; Mao, Yilei; Meng, Zhiqiang.
Afiliação
  • Zhou J; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Sun H; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang Z; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Cong W; Department of Pathology, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Zeng M; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhou W; The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Bie P; Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Liu L; Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Wen T; Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu, China.
  • Kuang M; Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Han G; Department of Liver Diseases and Digestive Interventional Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Yan Z; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang M; Department of Interventional Radiology, Chinese PLA General Hospital, Beijing, China.
  • Liu R; Department of Interventional Radiology, The Tumor Hospital of Harbin Medical University, Harbin, China.
  • Lu L; Department of Interventional Oncology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Ren Z; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zeng Z; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Liang P; Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China.
  • Liang C; Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Chen M; Editorial Department of Chinese Journal of Digestive Surgery, Chongqing, China.
  • Yan F; Department of Radiology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Wang W; Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Hou J; Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Ji Y; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yun J; Department of Pathology, Tumor Prevention and Treatment Center, Sun Yat-sen University, Guangzhou, China.
  • Bai X; Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Cai D; Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen W; Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.
  • Chen Y; Department of Hematology, Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Cheng W; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Cheng S; The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Dai C; Department of Hepatobiliary and Spleenary Surgery, The Affiliated Shengjing Hospital, China Medical University, Shenyang, China.
  • Guo W; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Guo Y; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Hua B; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
  • Huang X; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Jia W; Department of Hepatic Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei, China.
  • Li Q; Department of Oncology, West China Hospital, Sichuan University, Chengdu, China.
  • Li T; Department of General Surgery, Qilu Hospital, Shandong University, Jinan, China.
  • Li X; The First Hospital of Lanzhou University, Lanzhou, China.
  • Li Y; Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, China.
  • Li Y; Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liang J; Department of Oncology, Peking University International Hospital, Beijing, China.
  • Ling C; Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai, China.
  • Liu T; Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Liu X; Department of Medical Oncology, PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, China.
  • Lu S; Institute and Hospital of Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese PLA General Hospital, Beijing, China.
  • Lv G; Department of General Surgery, The First Hospital of Jilin University, Jilin, China.
  • Mao Y; Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.
  • Meng Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Liver Cancer ; 12(5): 405-444, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37901768
ABSTRACT

Background:

Primary liver cancer, of which around 75-85% is hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people.

Summary:

Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China in June 2017, which were updated by the National Health Commission in December 2019, additional high-quality evidence has emerged from researchers worldwide regarding the diagnosis, staging, and treatment of liver cancer, that requires the guidelines to be updated again. The new edition (2022 Edition) was written by more than 100 experts in the field of liver cancer in China, which not only reflects the real-world situation in China but also may reshape the nationwide diagnosis and treatment of liver cancer. Key Messages The new guideline aims to encourage the implementation of evidence-based practice and improve the national average 5-year survival rate for patients with liver cancer, as proposed in the "Health China 2030 Blueprint."
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Liver Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Liver Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China